THEO-24 200mg capsules

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

theophylline, Quantity: 200 mg

Commercializzato da:

Proqualix Pty Ltd - in Administration

Forma farmaceutica:

Capsule

Composizione:

Excipient Ingredients: colloidal anhydrous silica; ethylcellulose; Shellac; purified talc; titanium dioxide; Gelatin; carmoisine; quinoline yellow; maize starch; sucrose

Via di somministrazione:

Oral

Confezione:

Not Required

Tipo di ricetta:

Not scheduled. Not considered by committee

Indicazioni terapeutiche:

Standard indications for New Zealand and Singapore THEO-24 is indicated for the relief and/or prevention of symptoms of asthma and for reversable bronchospasm associated with chronic bronchitis and emphysema.

Dettagli prodotto:

Visual Identification: Opaque red-orange cap, clear-colourless body; printed in black ink "searle" and "2842" on one part, "THEO-24" and "200mg" on the other.; Container Type: Bottle

Stato dell'autorizzazione:

Listed (Export Only)

Data dell'autorizzazione:

1991-11-28